These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 6304566)

  • 1. Motility, rigidity and turnover of dopamine in the striatum after administration of morphine to rats: a re-evaluation of their mechanisms.
    Genç E; Havemann U; Tzoneva-Tyutyulkova N; Kuschinsky K
    Neuropharmacology; 1983 Apr; 22(4):471-6. PubMed ID: 6304566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of striatal lesions with kainic acid on morphine-induced "catatonia" and increase of striatal dopamine turnover.
    Havemann U; Winkler M; Genç E; Kuschinsky K
    Naunyn Schmiedebergs Arch Pharmacol; 1981 Aug; 317(1):44-50. PubMed ID: 7196998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of the substantia nigra in motility of the rat. Muscular rigidity, body asymmetry and catalepsy after injection of morphine into the nigra.
    Turski L; Havemann U; Kuschinsky K
    Neuropharmacology; 1983 Sep; 22(9):1039-48. PubMed ID: 6685231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of morphine in striatum and nucleus accumbens: relationship to pharmacological actions.
    Melzacka M; Nesselhut T; Havemann U; Vetulani J; Kuschinsky K
    Pharmacol Biochem Behav; 1985 Aug; 23(2):295-301. PubMed ID: 4059315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unilateral injection of morphine into the nucleus accumbens induces akinesia and catalepsy, but no spontaneous muscular rigidity in rats.
    Winkler M; Havemann U; Kuschinsky K
    Naunyn Schmiedebergs Arch Pharmacol; 1982 Feb; 318(3):143-7. PubMed ID: 7199627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of delta and mu opiopeptides on the turnover and release of dopamine in rat striatum.
    Yonehara N; Clouet DH
    J Pharmacol Exp Ther; 1984 Oct; 231(1):38-42. PubMed ID: 6092604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. On the possible role of excitatory amino acids in the striatum in mediating morphine-induced muscular rigidity.
    Turski L; Havemann U; Kuschinsky K
    Pharmacol Biochem Behav; 1982 Oct; 17(4):715-9. PubMed ID: 6757971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disinhibition of nigral GABA output neurons mediates muscular rigidity elicited by striatal opioid receptor stimulation.
    Turski L; Havemann U; Schwarz M; Kuschinsky K
    Life Sci; 1982 Nov 15-22; 31(20-21):2327-30. PubMed ID: 6298525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kainic acid-induced changes of serotonin and dopamine metabolism in the striatum and substantia nigra of the rat.
    Sperk G; Berger M; Hörtnagl H; Hornykiewicz O
    Eur J Pharmacol; 1981 Sep; 74(4):279-86. PubMed ID: 6170518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On the mechanisms of the development of tolerance to the muscular rigidity produced by morphine in rats.
    Themann P; Havemann U; Kuschinsky K
    Eur J Pharmacol; 1986 Oct; 129(3):315-21. PubMed ID: 3780846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of changes in locomotor activity with striatal homovanillic acid and 3,4-dihydroxyphenylacetic acid concentrations following the bilateral intranigral injection of dopamine agonist drugs in rats.
    Kelly E; Jenner P; Marsden CD
    J Pharm Pharmacol; 1987 Mar; 39(3):196-202. PubMed ID: 2883284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopamine release and metabolism in nucleus accumbens and striatum of morphine-tolerant and nontolerant rats.
    Johnson DW; Glick SD
    Pharmacol Biochem Behav; 1993 Oct; 46(2):341-7. PubMed ID: 8265688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for functional interactions of morphine in substantia nigra and striatum in relation to muscular rigidity in rats.
    Turski L; Havemann U; Kuschinsky K
    Neurosci Lett; 1982 Mar; 28(3):291-6. PubMed ID: 6281695
    [No Abstract]   [Full Text] [Related]  

  • 14. Morphine-stimulated metabolism of striatal and limbic dopamine is dissimilarly sensitized in rats upon withdrawal from chronic morphine treatment.
    Honkanen A; Piepponen TP; Ahtee L
    Neurosci Lett; 1994 Oct; 180(2):119-22. PubMed ID: 7700562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of naloxone on morphine-induced changes in striatal dopamine metabolism and glutamate, ascorbic acid and uric acid release in freely moving rats.
    Enrico P; Mura MA; Esposito G; Serra P; Migheli R; De Natale G; Desole MS; Miele M; Miele E
    Brain Res; 1998 Jun; 797(1):94-102. PubMed ID: 9630540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different action on dopamine catabolic pathways of two endogenous 1,2,3,4-tetrahydroisoquinolines with similar antidopaminergic properties.
    Antkiewicz-Michaluk L; Michaluk J; Mokrosz M; Romanska I; Lorenc-Koci E; Ohta S; Vetulani J
    J Neurochem; 2001 Jul; 78(1):100-8. PubMed ID: 11432977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo voltammetric study of dopamine release in the striatum following microinjection of apomorphine into the substantia nigra zona reticulata.
    Kamata K; Sugimoto A; Kameyama T
    Jpn J Pharmacol; 1986 Mar; 40(3):472-7. PubMed ID: 3712872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopamine receptor subsensitivity in the substantia nigra after chronic morphine treatment in rats.
    Spampinato U; Gozlan H; Daval G; Fattaccini CM; Hamon M
    Eur J Pharmacol; 1988 May; 150(1-2):113-22. PubMed ID: 2456939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of effect of intranigral administration of a dopamine analogue, (+/-)-3-(3-hydroxyphenyl)-N,n-propylpiperidine [(+/-)-3-PPP], on nigrostriatal dopamine neurones.
    Kelly E; Jenner P; Marsden CD
    Neurosci Lett; 1985 May; 56(1):57-62. PubMed ID: 4011049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Morphine and nigrostriatal function in the rat and mouse: the role of nigral and striatal opiate receptors.
    Wood PL; Richard JW
    Neuropharmacology; 1982 Dec; 21(12):1305-10. PubMed ID: 6296716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.